Cost-effectiveness of empirical ceftazidime-avibactam for hospital-acquired urinary tract infections: a modeling study identifying key beneficiary subgroups.
- DOI
- 10.1186/s12962-026-00805-1
- Published
- 2026-07-30
- Container
- Cost Eff Resour Alloc
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12962-026-00805-1,
title = {Cost-effectiveness of empirical ceftazidime-avibactam for hospital-acquired urinary tract infections: a modeling study identifying key beneficiary subgroups.},
author = {Wu BS and Chang YY and Chen SC and Lai CH and Huang CK and Tsai CT and Lin WR and Chung HC and Lin IF.},
year = {2026},
journal = {Cost Eff Resour Alloc},
doi = {10.1186/s12962-026-00805-1},
url = {https://doi.org/10.1186/s12962-026-00805-1}
}RIS
TY - JOUR TI - Cost-effectiveness of empirical ceftazidime-avibactam for hospital-acquired urinary tract infections: a modeling study identifying key beneficiary subgroups. AU - Wu BS AU - Chang YY AU - Chen SC AU - Lai CH AU - Huang CK AU - Tsai CT AU - Lin WR AU - Chung HC AU - Lin IF. PY - 2026 JO - Cost Eff Resour Alloc DO - 10.1186/s12962-026-00805-1 UR - https://doi.org/10.1186/s12962-026-00805-1 ER -
APA
BS, W., YY, C., SC, C., CH, L., CK, H., CT, T., WR, L., HC, C., & IF., L. (2026). Cost-effectiveness of empirical ceftazidime-avibactam for hospital-acquired urinary tract infections: a modeling study identifying key beneficiary subgroups.. Cost Eff Resour Alloc. https://doi.org/10.1186/s12962-026-00805-1
Source records
- europe-pmc · retrieved 2026-11-10T13:57:21.623Z
- doaj · retrieved 2026-11-10T13:57:21.710Z